Clinical Trials on Cancer Diagnosis in China

Total 7325 results

Peking University Third Hospital

Recruiting

Accuracy of Coplanar Template Assisted Seed Implantation for Abdominal and Pelvic Cancer

Accuracy of Coplanar Template Assisted Seed Implantation for Abdominal and Pelvic Cancer

China
Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA Mutations

Breast Cancer Metastatic

China
Genor Biopharma Co., Ltd.

Recruiting

A Phase Ib Study of GB491 Plus Letrozole in Patients With Advanced Breast Cancer

Advanced Breast Cancer

China
Peking University

Recruiting

Selective Omission of Axillary Surgery in Triple-negative and HER2-positive Breast Cancer After NACT

Breast Cancer Female

China
Peking Union Medical College Hospital

Recruiting

Evaluation of Prognostic Monitoring for Young Breast Cancer Patients

Breast Cancer Female

China
Peking Union Medical College Hospital

Recruiting

Survival Benefits of Statins in Breast Cancer Patients (SBSBC)

Breast Cancer Female

China
Shandong Luoxin Pharmaceutical Group Stock Co.,...

Completed

A Phase I Study of LX-039 Tablets

Advanced Breast Cancer

China
Fudan University

Completed

Prediction of 18F-FES-PET/CT Parameters on Palbociclib Combined With ET

Metastatic Breast Cancer

China
Shanghai Jiao Tong University School of Medicine
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Breast Cancer Invasive

China
Tao OUYANG
Peking University First Hospital; 307 Hospital of PLA; Peking University People... and other collaborators

Active, not recruiting

Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy

Primary Breast Cancer

China
Zhimin Shao

Completed

Study to Determine the Utility of FES-PET in the Prediction of Response to Fulvestrant in Women With Estrogen Positive Metastatic Breast Cancer

Metastatic Breast Cancer

China
Jiangsu HengRui Medicine Co., Ltd.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Completed

Study Evaluating Pyrotinib in Combination With Capecitabine In Patients With HER2 Positive Metastatic Breast Cancer (BLTN-Ic)

Metastatic Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients

Metastatic Breast Cancer

China
Shanghai CP Guojian Pharmaceutical Co., Ltd.

Completed

Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer

Metastatic Breast Cancer

China
Fudan University

Completed

Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC

Metastatic Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...
Beijing Shenogen Biomedical Co., Ltd

Unknown

Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients

Metastatic Breast Cancer

China
RenJi Hospital

Not yet recruiting

Dalpiciclib in HR+/HER2- ABC

Advanced Breast Cancer

China
RenJi Hospital

Recruiting

Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer (CORINNE-PI)

Breast Cancer Invasive

China
Fudan University
Chongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaborators

Recruiting

Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer

Breast Cancer Metastatic

China
Fudan University
Chongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaborators

Recruiting

PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer

Breast Cancer Metastatic

China
Peking Union Medical College Hospital

Recruiting

Prospective Research for Elderly (≥65 Years Old) Early Breast Cancer Patients (EEBC)

Breast Cancer Female

China
Fudan University

Not yet recruiting

Exploring Whether Disease-free Intervals Can Guide Endocrine Combined Targeted Therapy for ER+/HER2+ Advanced Breast Cancer (T-sunflower)

Metastatic Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

The Efficacy and Safety of Dalpiciclib Plus Endocrine Therapy in HR-positive / HER2-negative Advanced Breast Cancer Patients With Visceral Crisis

Advanced Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...
Beijing Huanxing Cancer Hospital

Recruiting

Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine

Metastatic Breast Cancer

China
Peking University

Recruiting

Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy

Invasive Breast Cancer

China
Tao OUYANG

Recruiting

Research of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant Chemotherapy

Primary Breast Cancer

China
Fudan University

Recruiting

Metronomic PLD in Patients With Primary Endocrine Resistant ABC

Advanced Breast Cancer

China
RenJi Hospital

Active, not recruiting

Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer (NeoATP)

Breast Cancer Female

China
The Hong Kong Polytechnic University
The Affiliated Hospital Of Southwest Medical University

Terminated

Acupuncture for Joint Symptoms in Patients With Breast Cancer

Female Breast Cancer

China
Fudan University

Active, not recruiting

Fulvestrant 500mg in Patients With Advanced Breast Cancer

Metastatic Breast Cancer

China
Taizhou EOC Pharma Co., Ltd.

Active, not recruiting

Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer

Advanced Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Hypofractionated Radiation Therapy With Concomitant Boost in Treating Women After Breast Conserving Surgery

Breast Cancer Female

China
Peking University

Completed

Comparison of CNB and Surgical Specimens for ER, PgR, HER2 Status and Ki67 Index in Invasive Breast Cancer.

Invasive Breast Cancer

China
Fudan University

Completed

A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer

Metastatic Breast Cancer

China
Fudan University

Completed

Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer

Breast Cancer Female

China
Xichun Hu

Completed

Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer

Metastatic Breast Cancer

China
Fudan University

Completed

A Phase II Study of Abraxane Gemcitabine Combination in Patients With Metastatic Breast Cancer

Metastatic Breast Cancer

China
Fudan University

Completed

Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) Patients

Metastatic Breast Cancer

China
Hospital Affiliated to Military Medical Science...

Unknown

The Study of Goserelin Plus Fulvestrant Comparing With Goserelin Plus Anastrozole for Advanced Breast Cancer (PROOF)

Metastatic Breast Cancer

China
Fudan University

Completed

A Combination of Abraxane and Cisplatin in Metastatic Breast Cancer

Metastatic Breast Cancer

China
Sun Yat-sen University

Unknown

Maintenance Treatment With S-1 in Gastric Cancer Patients

Gastric Cancer Stage IV | Cancer of Stomach

China
Shenzhen Yangli Pharmaceutical Technology Co., Ltd

Recruiting

Study of TFX06 in Women With Advanced Breast Cancer.

Metastatic Breast Cancer | ER+, HER2- Advanced Breast Cancer

China
Fudan University

Not yet recruiting

Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT Treatment (CHAMPION)

Metastatic Prostate Cancer | Castration-Sensitive Prostate Cancer

China
jianming xu
NeoCura

Recruiting

Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver Cancer

Gastric Cancer | Esophageal Cancer | Liver Cancer

China
RenJi Hospital

Recruiting

A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer

Pancreatic Cancer Metastatic | Pancreatic Cancer Stage IV

China
RenJi Hospital

Recruiting

Safety and Feasibility of Reversible Induction Strategy

Gastric Cancer | Colon Cancer | Prostatic Cancer | Patients With Uncertain Difficult Airway

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Study of SHR-A1909 in Subjects With Advanced Malignant Tumors

Advanced Malignant Cancer

China
Shandong University

Completed

Enhanced Recovery After Surgery (ERAS) in Gynecological Surgery (ERASGS-01) (ERAS)

Gynecologic Cancer | Gynecologic Disease

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

Phase II Neoadjuvant Pyrotinib Combined With Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial

Breast Cancer | Neoadjuvant Therapy | Hormone Receptor-positive Breast Cancer | HER2-low-expressing Breast Cancer

China
Guangdong Provincial People's Hospital
First Affiliated Hospital, Sun Yat-Sen University; Henan Cancer Hospital; Dongguan... and other collaborators

Completed

DCb (Docetaxel/Carboplatin) Versus EC-D (Epirubicin/Cyclophosphamide Followed by Docetaxe) as Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

Triple-Negative Breast Cancer

China

3

Subscribe